Shaperon (XKRX:378800) Short-Term Capital Lease Obligation : ₩195.83 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Shaperon Short-Term Capital Lease Obligation?

Shaperon's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₩195.83 Mil.

Shaperon's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (₩245.66 Mil) to Dec. 2024 (₩275.69 Mil) but then declined from Dec. 2024 (₩275.69 Mil) to Mar. 2025 (₩195.83 Mil).

Shaperon's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (₩178.06 Mil) to Dec. 2023 (₩294.17 Mil) but then declined from Dec. 2023 (₩294.17 Mil) to Dec. 2024 (₩275.69 Mil).

Shaperon Short-Term Capital Lease Obligation Historical Data

The historical data trend for Shaperon's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shaperon Short-Term Capital Lease Obligation Chart

Shaperon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

149.39

87.64

178.06

294.17

275.69

Shaperon Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial											293.10	283.53	245.66	275.69	195.83

Shaperon Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Shaperon Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shaperon's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shaperon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shaperon Inc (XKRX:378800) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gangnam Ace Tower G9, Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu, Seoul, KOR, 06373

Website

http://www.shaperon.com

Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient's quality of life by developing safe and efficacious drugs and immunotherapies.

Shaperon Headlines

No Headlines